SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Solvay Bank Corp. (SOBS) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 51/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SOBS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.44
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$20.92
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2008 |
$2.15 |
$20.96M |
$5.34M |
25.5% |
| 2009 |
$1.97 |
$22.11M |
$4.86M |
22% |
| 2012 |
$2.36 |
$27.57M |
$6.17M |
22.4% |
| 2019 |
$3.44 |
$30.33M |
$8.64M |
28.5% |
| 2020 |
$2.83 |
$35.85M |
$7.12M |
19.9% |
| 2021 |
$4.04 |
$36.87M |
$10.25M |
27.8% |
| 2022 |
$4.25 |
$37.54M |
$10.77M |
28.7% |
| 2023 |
$2.45 |
$42.55M |
$6.22M |
14.6% |
| 2024 |
$1.79 |
$52.07M |
$4.54M |
8.7% |
| 2025 |
$0.00 |
$53.04M |
$5.75M |
10.8% |
